Research Grants Awarded

Reseach grants support Minnesota scientific and medical research that has the potential to translate to clinical advances in regenerative medicine. Grants typically open every September. Learn more about how to apply for a grant by reading our frequently asked questions

 

View research grants awarded by year.
Elizabeth Siegler, PhD
Mesenchymal stromal cells (MSCs) have intrinsic immunosuppressive and regenerative properties. We seek to engineer MSCs with artificial receptors to…
2021-2023
Enis Kostallari, PhD
Public Health Relevance: Alcoholic Hepatitis (AH) is a severe liver disease and is a leading cause of morbidity and mortality in the United States of…
2021-2023
Matthew Abdel, MD
Joint stiffening (arthrofibrosis) is a debilitating complication with limited treatment options that is observed in a substantial subset of patients…
2021-2023
Isobel Scarisbrick, PhD
Our goal is to develop a new treatment strategy that improves outcomes in individuals with chronic spinal cord injury. Studies will contribute to the…
2021-2023
Brenda Ogle, PhD
The clinical prognosis for patients with hypertrophic cardiomyopathy (HCM) is very poor and the only long-term alternative is heart transplant. Our…
2021-2023
Walter Low, PhD
The goal of this research is to facilitate the generation of human organs and cells for transplantation and repair of the human body. The generation…
2021-2023
Harald Junge, PhD
Retinal vascular diseases, e.g., diabetic retinopathy, are a leading cause of blindness and place a significant burden on individual patients as well…
2021-2023
Daniel Garry, MD, PhD
Cardiovascular diseases are common and deadly. It is estimated that the U.S. has limited blood supply for those that require transfusions (there are…
2021-2023
Alfonso Eirin, MD
Obesity remains a significant health problem that affects above 30% of Minnesotans. Obesity increases susceptibility to injury by interfering with…
2021-2023
Jason Doles, PhD
Neuromuscular diseases (NMDs) are life-altering conditions typically resulting in disability, poor quality of life, and eventual long-term dependency…
2021-2023
Sanjay Mirsa, MD
In the US, ~726,000 patients have end-stage renal disease (ESRD) requiring chronic hemodialysis, which will double in the coming decade. Optimal…
2021-2023
Atta Behfar, MD, PhD
1. Deployment of scalable and affordable regenerative solutions for patients who have experienced heart attack. 2. Establishment of safety for a…
2021-2023